Amalgamated Bank Sells 259 Shares of Integer Holdings Corporation (NYSE:ITGR)

Amalgamated Bank reduced its holdings in shares of Integer Holdings Corporation (NYSE:ITGR) by 2.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,554 shares of the medical equipment provider’s stock after selling 259 shares during the quarter. Amalgamated Bank’s holdings in Integer were worth $1,127,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of the business. Bessemer Group Inc. lifted its stake in shares of Integer by 73.1% in the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider’s stock worth $35,000 after purchasing an additional 125 shares during the period. Yorktown Management & Research Co Inc bought a new stake in Integer in the first quarter worth $277,000. LVZ Inc. raised its holdings in shares of Integer by 7.9% in the first quarter. LVZ Inc. now owns 2,830 shares of the medical equipment provider’s stock worth $334,000 after buying an additional 207 shares during the period. North Growth Management Ltd. boosted its position in Integer by 1.0% in the 1st quarter. North Growth Management Ltd. now owns 98,000 shares of the medical equipment provider’s stock valued at $11,510,000 after buying an additional 1,000 shares during the period. Finally, QRG Capital Management Inc. lifted its holdings in shares of Integer by 1.0% in the 1st quarter. QRG Capital Management Inc. now owns 37,306 shares of the medical equipment provider’s stock worth $4,402,000 after buying an additional 368 shares during the period. 99.29% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Integer

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the company’s stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer owned 47,000 shares of the company’s stock, valued at $5,788,990. This represents a 87.82% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Martin C. Maxwell sold 8,720 shares of the business’s stock in a transaction on Thursday, June 5th. The shares were sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the sale, the director owned 22,170 shares in the company, valued at $2,672,815.20. This represents a 28.23% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 362,434 shares of company stock worth $44,577,115 over the last three months. 2.16% of the stock is currently owned by insiders.

Integer Stock Up 0.9%

Shares of NYSE:ITGR opened at $118.11 on Wednesday. The company has a 50 day moving average of $120.16 and a two-hundred day moving average of $125.29. The company has a market capitalization of $4.12 billion, a price-to-earnings ratio of 55.98, a price-to-earnings-growth ratio of 1.01 and a beta of 0.98. Integer Holdings Corporation has a 52-week low of $104.93 and a 52-week high of $146.36. The company has a quick ratio of 2.14, a current ratio of 3.40 and a debt-to-equity ratio of 0.78.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. Integer had a net margin of 4.38% and a return on equity of 11.95%. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.14 EPS. As a group, analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on ITGR shares. KeyCorp reduced their price target on Integer from $154.00 to $145.00 and set an “overweight” rating on the stock in a research report on Monday, April 21st. Truist Financial set a $150.00 price target on Integer and gave the company a “buy” rating in a research note on Friday, April 25th. Raymond James Financial upped their price target on shares of Integer from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, April 25th. Citigroup raised shares of Integer from a “hold” rating to a “strong-buy” rating and lifted their target price for the stock from $133.00 to $140.00 in a research note on Thursday, May 22nd. Finally, Wall Street Zen upgraded Integer from a “sell” rating to a “hold” rating in a report on Monday, May 19th. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $145.00.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.